The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

DSpace Repository

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Author: Boutry, Celine; Hastie, Andrew; Diez-Domingo, Javier; Tinoco, Juan Carlos; Yu, Chong-Jen; Andrews, Charles; Beytout, Jean; Caso, Covadonga; Cheng, Huey-Shinn; Cheong, Hee Jin; Choo, Eun Ju; Curiac, Dan; Di Paolo, Emmanuel; Dionne, Marc; Eckermann, Tamara; Esen, Meral; Ferguson, Murdo; Ghesquiere, Wayne; Hwang, Shinn-Jang; Avelino-Silva, Thiago Junqueira; Kosina, Pavel; Liu, Chiu-Shong; Markkula, Jukka; Moeckesch, Beate; de Oliveira, Claudia Murta; Park, Dae Won; Pauksens, Karlis; Pirrotta, Paola; Plassmann, Georg; Pretswell, Carol; Rombo, Lars; Salaun, Bruno; Berglund, Johan Sanmartin; Schenkenberger, Isabelle; Schwarz, Tino; Shi, Meng; Ukkonen, Benita; Zahaf, Toufik; Zerbini, Cristiano; Schuind, Anne; Cunningham, Anthony L.
Tübinger Autor(en):
Esen, Meral
Published in: Clinical Infectious Diseases (2022), Bd. 74, H. 8, S. 1459-1467
Verlagsangabe: Oxford Univ Press Inc
Language: English
Full text: http://dx.doi.org/10.1093/cid/ciab629
ISSN: 1058-4838
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)